Nick Pullen is the Chief Scientific Officer at ARTBIO. Prior to that, he held positions at Jnana Therapeutics, Bristol Myers Squibb, Celgene, Roche, and Pfizer, where he held various high-level roles in research and development. Nick's background includes a PhD in Biochemistry from the University of Southampton and extensive experience in the field of pharmaceuticals and biotechnology.